Carna Biosciences,Inc. [4572.T]
TOKYO, Apr 16 (Pulse News Wire) – Carna Biosciences,inc. (4572.T) announced that its board of directors resolved, to issue restricted shares to two employees.
The issuance will take place on May 13, 2026, with a total of 32,300 ordinary shares being distributed. Each share will be priced at ¥425, based on the closing price of the company's stock on the Tokyo Stock Exchange on April 15, 2026. Under the restricted share allocation program, employees will hold these shares for three years, during which time they cannot sell, pledge, or otherwise dispose of them. The restrictions will lift upon completion of their tenure as either officers or employees of the company until May 12, 2029.
In case of voluntary resignation or retirement, the company reserves the right to acquire the shares free of charge. Additionally, the shares will be managed separately in accounts held by Nomura Securities Co., Ltd. to ensure compliance with the restriction conditions. This initiative aims to incentivize long-term value creation among employees through equity participation.
The decision reflects the company’s commitment to aligning employee interests with sustained growth and performance.
🟢 Confidence: High AI-translated content.